Form 8-K - Current report:
SEC Accession No. 0000950170-22-026872
Filing Date
2022-12-21
Accepted
2022-12-21 16:35:19
Documents
13
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crbp-20221108.htm   iXBRL 8-K 57548
2 EX-99.1 crbp-ex99_1.htm EX-99.1 353578
  Complete submission text file 0000950170-22-026872.txt   543309

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbp-20221108.xsd EX-101.SCH 2469
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbp-20221108_lab.xml EX-101.LAB 13474
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbp-20221108_pre.xml EX-101.PRE 9900
7 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20221108_htm.xml XML 4767
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 221478830
SIC: 2834 Pharmaceutical Preparations